Le rapport bénéfice/risque des aGLP-1 est favorable lorsqu'ils sont utilisés conformément aux recommandations, assure l'ANSM.

M ounjaro et Ozempic sont deux des médicaments injectables les plus populaires pour aider à contrôler la glycémie chez les ...

Introduction : Le spectacle d’un président pharmacien Un site web estampillé Trump pour sauver l’Amérique malade Le 5 février 2026, Donald Trump a dévoilé son dernier coup marketing : TrumpRx.gov, un ...

By Dr. Priyom Bose, Ph.D. An examination of user reviews finds that people continue off-label Ozempic when it delivers ...

Ozempic-maker Novo Nordisk turned to the actors from Apple’s 2000s “Get a Mac” ads to differentiate its GLP-1 medication amid a rising sea of competitors. On January 20, the Danish pharmaceutical ...

L’ANSM a publié en janvier dernier les résultats de son enquête nationale sur les traitements antidiabétiques utilisés contre l’obésité.

Once known for bottomless breadsticks and supersized meals, American chain restaurants are increasingly rethinking their portion sizes. As GLP-1 weight-loss medications like Ozempic, Wegovy and ...

Drugmaker Novo Nordisk is running ads that play off Apple’s humorous early-aughts “Get a Mac” campaign to try to distinguish Ozempic from other GLP-1 drugs taken for Type 2 diabetes. The new ads ...

Novo Nordisk (NVO) stock pares losses as the company plans Ozempic pill launch in Q2 2026 after FDA OKs the name for several oral semaglutide doses. Read more here.

Amid a viral social media trend glorifying the halcyon days of 2016, Novo Nordisk has gone back an extra decade to find inspiration for its latest direct-to-consumer Ozempic campaign. The new ads hark ...

The companies, which are yet to announce the approval, did not immediately respond to Reuters' request for a comment. Sun Pharma, which is India's largest drugmaker by revenue, on Friday announced ...

Jan 28 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab spent nearly $500 million on U.S. advertising for its GLP-1 drugs Wegovy and Ozempic in the first nine months of 2025, more than double what ...